SCHEMBL19686151

SCHEMBL19686151

O=C1c2cc(-n3c4ccc(N(c5ccccc5)c5ccccc5)cc4c4cc(N(c5ccccc5)c5ccccc5)ccc43)ccc2CN1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
PKM P14618 3/20 0.40
HTR1A P08908 1/20 0.38
ADRA1A P35348 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
TP53 P04637 2/20 0.37
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
PGR P06401 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
NFKB1 P19838 1/20 0.37
DRD1 P21728 1/20 0.37
HTT P42858 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19686000 0.86 APP (0.35) NPC1RAB9APKMSMN1; SMN2LMNA
SCHEMBL19685938 0.85 NPC1 (0.59) NPC1RAB9APKMHTR1AADRA1A
SCHEMBL19686135 0.84 NPC1 (0.52) NPC1RAB9APKMHTR1AADRA1A
SCHEMBL19686154 0.82 NPC1 (0.50) NPC1RAB9APKMHTR1AADRA1A
SCHEMBL19685760 0.80 MAOB (0.41) LMNAMEN1KMT2AKDM4EAPP
SCHEMBL19685939 0.79 NPC1 (0.55) NPC1RAB9APKMHTR1AADRA1A
SCHEMBL19685700 0.78 MAOA (0.39) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL19686167 0.78 APP (0.33) LMNAAPP
SCHEMBL19685771 0.77 APP (0.35) NPC1RAB9APKMSMN1; SMN2LMNA
SCHEMBL13301593 0.77 KDM4E (0.46) PKMSMN1; SMN2LMNAMEN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS NPC1 4513/4885RAB9A 3747/4885PKM 1499/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS NPC1 4513/4885RAB9A 3747/4885PKM 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.